Clinical Trial Update: Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atezolizumab with carboplatin/paclitaxel in elderly patients with advanced non-small cell lung cancer; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non Small Cell Lung Cancer Metastatic | Phase 3 | Status: ACTIVE_NOT_RECRUITING